IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets

Suzanne M Garland; Neerja Bhatla; Yin Ling Woo; IPVS Policy Committee

doi:10.1016/j.vaccine.2024.126400

IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets

Vaccine. 2024 Dec 2;42(26):126400. doi: 10.1016/j.vaccine.2024.126400. Epub 2024 Oct 2.

Authors

Suzanne M Garland¹, Neerja Bhatla², Yin Ling Woo³; IPVS Policy Committee

Collaborators

IPVS Policy Committee:
Margaret Stanley⁴, Andreas Kaufmann⁵, Julia Brotherton⁶, Anna-Barbara Moscicki⁷, Anna Giuliano⁸, Karen Chan⁹, Sarah Feldman¹⁰, Nicolas Wentzensen¹¹, Kimon Chatzistamatiou¹²

Affiliations

¹ Reproductive & Neonatal Infectious Diseases, Department of Obstetrics and Gynaecology, University of Melbourne, Director Centre Women's Infectious Diseases Research, Honorary Research Fellow, Infection & Immunity, Murdoch Children's Research Institute, Parkville, VIC 3052, Australia. Electronic address: Suzanne.Garland@thewomens.org.au.
² Department of Obstetrics & Gynaecology, Room 3101, Teaching Block, All India Institute of Medical Sciences, New Delhi 110029, India.
³ Department of Obstetric and Gynaecology, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, W.Persekutuan Kuala Lumpur, Malaysia. Electronic address: ylwoo@ummc.edu.my.
⁴ Department of Pathology, University of Cambridge, UK.
⁵ Department of Gynecology, Charité-Universitätsmedizin, Berlin, Germany.
⁶ Professor of Cancer Prevention Policy and Implementation in the Evaluation and Implementation Science Unit, Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
⁷ Adolescent and Young Adult Medicine, Professor of Pediatrics, David Greffen School of Medicine, University of California, Los Angeles, United States.
⁸ Professor and Director Center for Immunization and Infection Research in Cancer (CIIRC), H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.
⁹ Department of Obstetrics and Gynaecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
¹⁰ Director Ambulatory Gynecologic Oncology and Center for Pre-invasive Disease of the Lower Genital Tract Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Brigham and Women's Hospital, USA.
¹¹ Senior Investigator, Head, Clinical Epidemiology Unit, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute, USA.
¹² Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Greece.

PMID: 39366196
DOI: 10.1016/j.vaccine.2024.126400

Abstract

The global supply of human papillomavirus (HPV) prophylactic vaccines has been constrained since 2020.Vaccine manufacturers have increased capacity and new HPV vaccines are now available. Vaccine supply is now able to meet the full HPV vaccine demand which has been achieved earlier than predicted.

Keywords: Human papillomavirus (HPV); Vaccine supply constraint.

MeSH terms

Female
Humans
Papillomavirus Infections* / prevention & control
Papillomavirus Vaccines* / administration & dosage
Papillomavirus Vaccines* / immunology
Uterine Cervical Neoplasms / prevention & control
Vaccination* / methods
World Health Organization*

Substances

Papillomavirus Vaccines